These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 24105952)

  • 1. The toll-like receptor 3 ligand, poly(I:C), improves immunosuppressive function and therapeutic effect of mesenchymal stem cells on sepsis via inhibiting MiR-143.
    Zhao X; Liu D; Gong W; Zhao G; Liu L; Yang L; Hou Y
    Stem Cells; 2014 Feb; 32(2):521-33. PubMed ID: 24105952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression and role of miR-301a in human umbilical cord-derived mesenchymal stromal cells.
    Ma F; Chen D; Chi Y; Chen F; Li X; Han Z
    Cytotherapy; 2013 Dec; 15(12):1511-6. PubMed ID: 24035358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and role of Toll-like receptors on human umbilical cord mesenchymal stromal cells.
    Chen D; Ma F; Xu S; Yang S; Chen F; Rong L; Chi Y; Zhao Q; Lu S; Han Z; Pang A; Han Z
    Cytotherapy; 2013 Apr; 15(4):423-33. PubMed ID: 23352460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No significant effects of Poly(I:C) on human umbilical cord-derived mesenchymal stem cells in the treatment of B6.MRL-Fas(lpr) mice.
    Huang S; Wang D; Gu F; Zhang Z; Deng W; Chen W; Tang X; Yao G; Feng X; Sun L
    Curr Res Transl Med; 2016; 64(2):55-60. PubMed ID: 27316386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-181a regulates local immune balance by inhibiting proliferation and immunosuppressive properties of mesenchymal stem cells.
    Liu L; Wang Y; Fan H; Zhao X; Liu D; Hu Y; Kidd AR; Bao J; Hou Y
    Stem Cells; 2012 Aug; 30(8):1756-70. PubMed ID: 22714950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An increase in CD3+CD4+CD25+ regulatory T cells after administration of umbilical cord-derived mesenchymal stem cells during sepsis.
    Chao YH; Wu HP; Wu KH; Tsai YG; Peng CT; Lin KC; Chao WR; Lee MS; Fu YC
    PLoS One; 2014; 9(10):e110338. PubMed ID: 25337817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Toll-like receptor 3 and 4 in regulating the function of mesenchymal stem cells isolated from umbilical cord.
    Zhang L; Liu D; Pu D; Wang Y; Li L; He Y; Li Y; Li L; Qiu Z; Zhao S; Li W
    Int J Mol Med; 2015 Apr; 35(4):1003-10. PubMed ID: 25695694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
    Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
    Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of mesenchymal stem cells under the stimulation of Toll-like receptor agonists.
    Chen X; Zhang ZY; Zhou H; Zhou GW
    Dev Growth Differ; 2014 Apr; 56(3):233-44. PubMed ID: 24645700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR3 preconditioning enhances the therapeutic efficacy of umbilical cord mesenchymal stem cells in TNBS-induced colitis via the TLR3-Jagged-1-Notch-1 pathway.
    Qiu Y; Guo J; Mao R; Chao K; Chen BL; He Y; Zeng ZR; Zhang SH; Chen MH
    Mucosal Immunol; 2017 May; 10(3):727-742. PubMed ID: 27649928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tonsil-derived mesenchymal stromal cells produce CXCR2-binding chemokines and acquire follicular dendritic cell-like phenotypes under TLR3 stimulation.
    Ryu JH; Park M; Kim BK; Ryu KH; Woo SY
    Cytokine; 2015 Jun; 73(2):225-35. PubMed ID: 25794662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal miR-146a Contributes to the Enhanced Therapeutic Efficacy of Interleukin-1β-Primed Mesenchymal Stem Cells Against Sepsis.
    Song Y; Dou H; Li X; Zhao X; Li Y; Liu D; Ji J; Liu F; Ding L; Ni Y; Hou Y
    Stem Cells; 2017 May; 35(5):1208-1221. PubMed ID: 28090688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation reveals Osterix regulation by miR-31.
    Baglìo SR; Devescovi V; Granchi D; Baldini N
    Gene; 2013 Sep; 527(1):321-31. PubMed ID: 23827457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 3 pre-conditioning increases the therapeutic efficacy of umbilical cord mesenchymal stromal cells in a dextran sulfate sodium-induced colitis model.
    Fuenzalida P; Kurte M; Fernández-O'ryan C; Ibañez C; Gauthier-Abeliuk M; Vega-Letter AM; Gonzalez P; Irarrázabal C; Quezada N; Figueroa F; Carrión F
    Cytotherapy; 2016 May; 18(5):630-41. PubMed ID: 27059200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR3 or TLR4 Activation Enhances Mesenchymal Stromal Cell-Mediated Treg Induction via Notch Signaling.
    Rashedi I; Gómez-Aristizábal A; Wang XH; Viswanathan S; Keating A
    Stem Cells; 2017 Jan; 35(1):265-275. PubMed ID: 27571579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Umbilical Cord-Derived Mesenchymal Stem Cell-Derived Exosomal MicroRNAs Suppress Myofibroblast Differentiation by Inhibiting the Transforming Growth Factor-β/SMAD2 Pathway During Wound Healing.
    Fang S; Xu C; Zhang Y; Xue C; Yang C; Bi H; Qian X; Wu M; Ji K; Zhao Y; Wang Y; Liu H; Xing X
    Stem Cells Transl Med; 2016 Oct; 5(10):1425-1439. PubMed ID: 27388239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal miR-223 Contributes to Mesenchymal Stem Cell-Elicited Cardioprotection in Polymicrobial Sepsis.
    Wang X; Gu H; Qin D; Yang L; Huang W; Essandoh K; Wang Y; Caldwell CC; Peng T; Zingarelli B; Fan GC
    Sci Rep; 2015 Sep; 5():13721. PubMed ID: 26348153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priming of Toll-like receptor 4 pathway in mesenchymal stem cells increases expression of B cell activating factor.
    Yan H; Wu M; Yuan Y; Wang ZZ; Jiang H; Chen T
    Biochem Biophys Res Commun; 2014 May; 448(2):212-7. PubMed ID: 24780395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
    Huang F; Zhu X; Hu XQ; Fang ZF; Tang L; Lu XL; Zhou SH
    Int J Mol Med; 2013 Feb; 31(2):484-92. PubMed ID: 23229021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA hsa-miR-138 inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells through adenovirus EID-1.
    Yang Z; Bian C; Zhou H; Huang S; Wang S; Liao L; Zhao RC
    Stem Cells Dev; 2011 Feb; 20(2):259-67. PubMed ID: 20486779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.